- USDA AMS's final rule amends several swine, lamb reporting provisions
- Updated Nutrition Composition Tables
- Meat label preferences explored
- Cover crops info at the click of a mouse
- Antibiotic alternative aids immune response
- 2015 Feed Composition Tables
- Weed Control Guide for Ohio, Indiana and Illinois
- August 2016 (1)
- September 2015 (1)
- July 2015 (1)
- June 2015 (2)
- April 2015 (1)
- January 2015 (1)
- August 2014 (2)
- July 2014 (1)
- June 2014 (1)
- May 2014 (1)
- April 2014 (1)
- January 2014 (1)
- May 2013 (1)
- March 2013 (1)
16 Total Posts
follow our RSS feed
Wednesday, June 25, 2014
Many of you know that I have provided programming to small ruminant producers about anthelmintic resistance. It is an for all livestock producers. If we keep using dewormers indiscriminately, we may lose the efficacy of these tools. To avoid the development of drug resistance by parasites, the treatments must be targeted for when they are most effective, and done as infrequently as possible.
While this research was completed in swine, it does provide hope for the potential development for other species.
June 23, 2014
After two moderate doses of a bacteria-derived protein were fed to worm-infected swine in an experiment, all intestinal roundworm larvae in the swine were damaged or destroyed and the infection was nearly completely eliminated, according to U.S. Department of Agriculture (USDA) and University of California-San Diego scientists.
The research team included microbiologist Joseph Urban and his colleagues at the USDA Agricultural Research Service (ARS) Beltsville Human Nutrition Research Center in Beltsville, Maryland, and Raffi Aroian and Yan Hu at the University of California-San Diego. ARS is USDA's chief intramural scientific research agency.
The parasitic roundworm that commonly infects pigs is Ascaris suum, which is genetically similar to A. lumbricoides, a roundworm species that infects about 1 billion people worldwide. A. suum infection in pigs is considered a good model for A. lumbricoides infection in humans because of its similar migration through the body and to the intestines.
During the experiments, the team used a crystal protein called "Cry5B," provided by Aroian's group, which is derived from the soil bacterium Bacillus thuringiensis. Cry5B protein is considered nontoxic to vertebrates and mammals.
The dosage the team provided in the study is comparable to the dose range used in existing commercial antiparasitic drugs. The results show the potential of Cry5B to treat Ascaris infections in pigs and other livestock and to work effectively in the human gastrointestinal tract, according to authors. The team described the research in a 2013 article published in PLOS: Neglected Tropical Diseases.
There is a need for more practical delivery systems for antiparasitic drug treatments, according to the scientists, and further cooperative research is planned.
Read more about this research in the May/June 2014 issue of Agricultural Research magazine.